KWIK-STIK, ANA (3 Strains) QC Set, REF 5065P; Microbiological testing

FDA Device Recall #Z-2576-2023 — Class III — August 14, 2023

Recall Summary

Recall Number Z-2576-2023
Classification Class III — Low risk
Date Initiated August 14, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Microbiologics Inc
Location Saint Cloud, MN
Product Type Devices
Quantity 4 units

Product Description

KWIK-STIK, ANA (3 Strains) QC Set, REF 5065P; Microbiological testing

Reason for Recall

One lot of KWIK STIK ANA (3 strains) QC Set is missing one of the strains, 6018P Parabacteroides distasonis.

Distribution Pattern

US Nationwide distribution in the states of MN, PA, TN, TX.

Lot / Code Information

UDI/DI 70845357025622, Lot Number 5065-26, Exp. 07/31/2024

Other Recalls from Microbiologics Inc

Recall # Classification Product Date
Z-0986-2026 Class II LYFO DISK, Campylobacter jejuni subsp. jejuni d... Dec 2, 2025
Z-0984-2026 Class II KWIK-STIK 2-Pack, Campylobacter jejuni subsp. j... Dec 2, 2025
Z-0985-2026 Class II KWIK-STIK 6-Pack, Campylobacter jejuni subsp. j... Dec 2, 2025
Z-0876-2026 Class II KWIK-STIK, Quality control kit for culture medi... Nov 13, 2025
Z-2194-2025 Class II LYFO-DISK, M. Canis Derived from ATCC 36299, pa... Jun 27, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.